|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Short-term investments in debt securities | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventories, net | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets | ||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Long-term investments in debt securities | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Payroll-related accruals | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Operating lease liabilities, current portion | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Operating lease liabilities, noncurrent portion | ||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||
| Other long-term liability | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | ||||||||||||||||||
| Common stock, $0.001 par value, 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 58,435,576 and 57,762,414 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||
Loading...
